Premium
The Hemorrhagic Risk: How to Evaluate It
Author(s) -
DI FUSCO STEFANIA ANGELA,
COLIVICCHI FURIO,
SANTINI MASSIMO
Publication year - 2013
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/pace.12146
Subject(s) - medicine , antithrombotic , atrial fibrillation , intensive care medicine , major bleeding , anticoagulant , risk assessment , relevance (law) , computer security , computer science , political science , law
This issue addresses the evaluation of hemorrhagic risk during antithrombotic treatment in atrial fibrillation patients. It illustrates the relevance of bleeding complications in the management of anticoagulation therapy and demonstrates the size of the problem among patients taking old and novel oral anticoagulant drugs. A survey of the main factors affecting the bleeding risk with pertinent supporting evidence is performed. Finally the paper discusses how to estimate the individual bleeding risk focusing on the HAS‐BLED score, whose use is recommended by international guidelines.